SMMT
NASDAQ
$13.50
Summit Therapeutics Inc (SMMT)
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America, and Europe. The company is headquartered in Cambridge, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $28.80 (+113.33%)
Market Cap
$12B
FCF 5Y CAGR
+43.02%
Free Cash Flow Yield
-3.29%
Beta (5Y)
1.75
Price Chart
Valuation
Market Cap$12B
Forward P/E3.72
P/S3891.31
P/B21.77
Profitability
Gross Profit (TTM)$705K
EBITDA-$1.21B
EPS-$1.60
Financial Health
Free Cash Flow Yield-3.29%
Growth & Risk
FCF 5Y CAGR+43.02%
Beta (5Y)1.75
Sharpe Ratio-0.66